Trial NCT00434356

View at ClinicalTrials.gov 
Org. Study IDs: AVF4057g

Last trial update was posted on 2009-12-03

MeSH Interventions

Bevacizumab Paclitaxel Sunitinib

MeSH Conditions

Breast Neoplasms

Other Conditions

Metastatic Breast Cancer

Stopping Reasons

Based on data collected, the combination appeared to be poorly tolearated.

Limitations And Caveats

Based on the early safety results from this study, further recruitment and treatment was halted. Insufficient efficacy data were available to perform all protocol-specified analyses and limited the interpretation of the analyses performed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID